CN1723894A - 含有(r)-3-[(s)-(5-氧-2-吡咯烷基)羰基]-噻唑烷-4-羧基的滴丸剂型及其制备方法 - Google Patents
含有(r)-3-[(s)-(5-氧-2-吡咯烷基)羰基]-噻唑烷-4-羧基的滴丸剂型及其制备方法 Download PDFInfo
- Publication number
- CN1723894A CN1723894A CN 200510041063 CN200510041063A CN1723894A CN 1723894 A CN1723894 A CN 1723894A CN 200510041063 CN200510041063 CN 200510041063 CN 200510041063 A CN200510041063 A CN 200510041063A CN 1723894 A CN1723894 A CN 1723894A
- Authority
- CN
- China
- Prior art keywords
- carboxyl
- thiazolidine
- pyrrolidinyl
- carbonyl
- oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100410632A CN100506227C (zh) | 2005-07-15 | 2005-07-15 | 含有(r)-3-[(s)-(5-氧-2-吡咯烷基)羰基]-噻唑烷-4-羧基的滴丸剂型及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100410632A CN100506227C (zh) | 2005-07-15 | 2005-07-15 | 含有(r)-3-[(s)-(5-氧-2-吡咯烷基)羰基]-噻唑烷-4-羧基的滴丸剂型及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1723894A true CN1723894A (zh) | 2006-01-25 |
CN100506227C CN100506227C (zh) | 2009-07-01 |
Family
ID=35923609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100410632A Active CN100506227C (zh) | 2005-07-15 | 2005-07-15 | 含有(r)-3-[(s)-(5-氧-2-吡咯烷基)羰基]-噻唑烷-4-羧基的滴丸剂型及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100506227C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102167727A (zh) * | 2011-01-29 | 2011-08-31 | 浙江金立源药业有限公司 | 一种匹多莫德的合成方法 |
-
2005
- 2005-07-15 CN CNB2005100410632A patent/CN100506227C/zh active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102167727A (zh) * | 2011-01-29 | 2011-08-31 | 浙江金立源药业有限公司 | 一种匹多莫德的合成方法 |
CN102167727B (zh) * | 2011-01-29 | 2013-05-15 | 浙江金立源药业有限公司 | 一种匹多莫德的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100506227C (zh) | 2009-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG97458A (bg) | Продукти и методи за лечение на храносмилателнияапарат | |
CN1166408C (zh) | 口服给药后能够长时间释放曲美他嗪的基质片 | |
CZ369292A3 (en) | Per-orally applicable form of a medicament for treating central states of dopamine insufficiency | |
HRP20000213A2 (en) | Extended release formulation | |
CN1893956A (zh) | 多西环素金属络合物固体剂型 | |
CN1186014C (zh) | 程序化和随时间释放的多颗粒药物剂型及其制备方法 | |
US7666860B2 (en) | Melt-formulated, multi-particulate oral dosage form | |
CN1223589C (zh) | 穿心莲内酯琥珀酸半酯钠钾盐及其制剂 | |
CN1857676A (zh) | 一种莪术油微胶囊制剂及其制备方法 | |
EP3068383B1 (en) | Solid compositions of triglycerides and uses thereof | |
TW200932286A (en) | Oral particulate antitumor preparation | |
CN1723894A (zh) | 含有(r)-3-[(s)-(5-氧-2-吡咯烷基)羰基]-噻唑烷-4-羧基的滴丸剂型及其制备方法 | |
CN1803811A (zh) | 一类硝基咪唑衍生物、制备方法及用途 | |
EA011215B1 (ru) | Терапевтическая система, содержащая амоксициллин и клавулановую кислоту, плавающая капсула | |
CN1833652A (zh) | 一种福多斯坦与克拉霉素的缓释组合制剂 | |
CN1058715A (zh) | 异环磷酰胺为活性成分的固体口服制剂 | |
CN101032507A (zh) | 一种红霉素纳米乳抗菌药物及其制备方法 | |
CN1319533C (zh) | 盐酸头孢他美酯分散片及其制备方法 | |
WO2014013928A1 (ja) | 安定化された内服用固形製剤 | |
CN107556304B (zh) | 一种硝基咪唑类药物及其制备方法和用途 | |
CN1080851A (zh) | 生长激素释放抑制因子的增强剂 | |
CN1827117A (zh) | 复方醋酸棉酚缓释药剂 | |
CN1709273A (zh) | 一种罗红霉素软胶囊及其制备方法 | |
CN1903869A (zh) | 替比夫定的衍生物盐及其制备方法和药物应用 | |
CN112972395B (zh) | 胶囊制剂及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU WUZHONG PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER OWNER: CHANGZHENG-XINKAI PHARMACEUTIC CO., LTD., SUZHOU Effective date: 20130808 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130808 Address after: Soochow road 215128 in Jiangsu Province, Suzhou Wuzhong Economic Development Zone No. 2 Building 8 Patentee after: Jiangsu Wuzhong Medical Group Co.,Ltd. Address before: 215128 No. 2, Soochow South Road, Jiangsu, Suzhou Patentee before: Changzheng-Xinkai Pharmaceutical Co., Ltd., Suzhou |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161026 Address after: Soochow road 215128 in Jiangsu Province, Suzhou Wuzhong Economic Development Zone No. 2 Building 8 Patentee after: Jiangsu Wuzhong Medical Group Co.,Ltd. Patentee after: Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. Suzhou pharmaceutical factory Address before: Soochow road 215128 in Jiangsu Province, Suzhou Wuzhong Economic Development Zone No. 2 Building 8 Patentee before: Jiangsu Wuzhong Medical Group Co.,Ltd. |